LLY

1,054.27

-0.65%↓

JNJ

209.54

-2.29%↓

ABBV

223.9

-1.64%↓

UNH

334.13

-2.12%↓

AZN

91.41

-0.2%↓

LLY

1,054.27

-0.65%↓

JNJ

209.54

-2.29%↓

ABBV

223.9

-1.64%↓

UNH

334.13

-2.12%↓

AZN

91.41

-0.2%↓

LLY

1,054.27

-0.65%↓

JNJ

209.54

-2.29%↓

ABBV

223.9

-1.64%↓

UNH

334.13

-2.12%↓

AZN

91.41

-0.2%↓

LLY

1,054.27

-0.65%↓

JNJ

209.54

-2.29%↓

ABBV

223.9

-1.64%↓

UNH

334.13

-2.12%↓

AZN

91.41

-0.2%↓

LLY

1,054.27

-0.65%↓

JNJ

209.54

-2.29%↓

ABBV

223.9

-1.64%↓

UNH

334.13

-2.12%↓

AZN

91.41

-0.2%↓

Search

Cencora Inc

Closed

SectorHealthcare

341.7 -2.46

Overview

Share price change

24h

Current

Min

339.76

Max

350

Key metrics

By Trading Economics

Income

-1B

-340M

Sales

3.1B

84B

P/E

Sector Avg

44.065

77.671

EPS

3.84

Dividend yield

0.64

Profit margin

-0.406

Employees

47,000

EBITDA

-1.1B

150M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+12.13% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.64%

2.35%

Market Stats

By TradingEconomics

Market Cap

1.9B

68B

Previous open

344.16

Previous close

341.7

Cencora Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

16 gru 2025, 23:46 UTC

Market Talk

Gold Edges Higher, Aided by Fed Rate-Cut Prospects -- Market Talk

16 gru 2025, 23:38 UTC

Market Talk

Nikkei May Rise on Possible Bargain-Hunting Interest -- Market Talk

16 gru 2025, 22:35 UTC

Acquisitions, Mergers, Takeovers

Santos: Sale Delivered Cash, Reduced Future Decommissioning Exposure

16 gru 2025, 22:35 UTC

Acquisitions, Mergers, Takeovers

Santos Sold 43% Stake in Petrel Fields, 100% of Tern Fields to Eni Australia

16 gru 2025, 22:33 UTC

Acquisitions, Mergers, Takeovers

Santos: A$40M Upfront Consideration, Up to A$20M in Contingent Payments

16 gru 2025, 22:33 UTC

Acquisitions, Mergers, Takeovers

Santos Sold 43% Operated Interest in Mahalo JV to Comet Ridge

16 gru 2025, 22:32 UTC

Acquisitions, Mergers, Takeovers

Santos Divests Two Noncore Assets as Part of Portfolio Optimization

16 gru 2025, 22:25 UTC

Acquisitions, Mergers, Takeovers

Westgold's Indicative Timetable Points to Early February Completion

16 gru 2025, 22:24 UTC

Acquisitions, Mergers, Takeovers

Westgold: Divestment Aligns With Broader Corporate Strategy

16 gru 2025, 22:23 UTC

Acquisitions, Mergers, Takeovers

Westgold: Deferred Payment Based on Performance Hurdles

16 gru 2025, 22:23 UTC

Acquisitions, Mergers, Takeovers

Westgold Will Receive A$15M Cash, A$19.6M in Alicanto Shares

16 gru 2025, 22:23 UTC

Acquisitions, Mergers, Takeovers

Westgold to Receive A$30M Deferred Payment in Cash or Shares

16 gru 2025, 22:22 UTC

Acquisitions, Mergers, Takeovers

Westgold Divesting Noncore Operating Asset for A$64.6M

16 gru 2025, 22:22 UTC

Acquisitions, Mergers, Takeovers

Westgold Agrees to Sell Mt Henry-Selene Project to Alicanto Minerals

16 gru 2025, 21:53 UTC

Earnings

Lennar Misses Earnings Estimates. The Stock Is Dropping. -- Barrons.com

16 gru 2025, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

16 gru 2025, 21:33 UTC

Acquisitions, Mergers, Takeovers

Warner Preparing to Tell Shareholders to Reject Paramount Offer -- 2nd Update

16 gru 2025, 21:18 UTC

Acquisitions, Mergers, Takeovers

Warner Preparing to Tell Shareholders to Reject Paramount Offer -- Update

16 gru 2025, 21:17 UTC

Acquisitions, Mergers, Takeovers

Worthington Enterprises to Buy LSI Group for About $205M >WOR

16 gru 2025, 21:16 UTC

Earnings

Worthington Enterprises 2Q Sales $327.5M >WOR

16 gru 2025, 21:16 UTC

Earnings

Worthington Enterprises 2Q Adj EPS 65c >WOR

16 gru 2025, 21:16 UTC

Earnings

Worthington Enterprises 2Q EPS 55c >WOR

16 gru 2025, 21:15 UTC

Acquisitions, Mergers, Takeovers

Worthington Enterprises Agrees To Acquire Leading Metal Roof Components Manufacturer LSI Group >WOR

16 gru 2025, 21:05 UTC

Acquisitions, Mergers, Takeovers

Ecolab Closes Acquisition Of Ovivo's Electronics Ultrapure Water Business >ECL

16 gru 2025, 20:54 UTC

Acquisitions, Mergers, Takeovers

Warner to Reject Paramount Offer As Soon As Wednesday, Sources Say -- WSJ

16 gru 2025, 20:54 UTC

Acquisitions, Mergers, Takeovers

Warner Preparing to Tell Shareholders to Reject Paramount Offer -- WSJ

16 gru 2025, 20:54 UTC

Acquisitions, Mergers, Takeovers

Warner to Recommend Existing Netflix Deal, Sources Say -- WSJ

16 gru 2025, 20:44 UTC

Market Talk

Russia-Ukraine Peace Efforts Send Crude to Near 5-Year Low -- Market Talk

16 gru 2025, 20:04 UTC

Market Talk

U.S. Natural Gas Extends Weather-Driven Losing Streak -- Market Talk

16 gru 2025, 20:01 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

Peer Comparison

Price change

Cencora Inc Forecast

Price Target

By TipRanks

12.13% upside

12 Months Forecast

Average 392.82 USD  12.13%

High 417 USD

Low 361 USD

Based on 11 Wall Street analysts offering 12 month price targets forCencora Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

11 ratings

10

Buy

1

Hold

0

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Cencora Inc

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
help-icon Live chat